Meghna S. Jayaraman

Meghna S. Jayaraman

Auto-generated profile, based on publicly available information

Meghna S. Jayaraman

Division of Pediatric Surgery, Department of Surgery, Phoenix Children's Hospital, 1919 E Thomas Rd., Phoenix, AZ, 85016, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
MJMeghna S. Jayaraman
Meghna S. Jayaraman
KGKaitlin Graham
Kaitlin Graham
EUEvan C. Unger
Evan C. Unger
The aim of this paper was to create an in vitro setup to quantify the oxygen offloading capabilities of dodecafluoropentane emulsion (DDFPe) in a hypoxic environment. Oxygen offloading from DDFPe was characterized under different gaseous environments and under pre-oxygenated conditions. Results of this study showed that (1) oxygen offloading is inversely related to the solubility of the selected sparging gas in saline and (2) both pre-oxygenated and simultaneously oxygenated DDFPe display similar magnitudes of oxygen transport. These results could be applicable to on-going and future studies involving a variety of hypoxic conditions where oxygen delivery might be therapeutically beneficial.

10 January 2023 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
GCGrant L. Collins
Grant L. Collins
AHAngela E. Hargis-Villanueva
Angela E. Hargis-Villanueva
MJMeghna S. Jayaraman
Meghna S. Jayaraman
KLKrista Lai
Krista Lai
EWErica M. Weidler
Erica M. Weidler
KLKathleen Van Leeuwen
Kathleen Van Leeuwen

1 January 2021 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
MJMeghna S. Jayaraman
Meghna S. Jayaraman
KGKaitlin Graham
Kaitlin Graham
EUEvan C. Unger
Evan C. Unger
The aim of this paper was to utilise an existing in vitro setup to quantify the oxygen offloading capabilities of two different subsets of injectable oxygenation therapeutics: (1) artificial oxygen carriers (AOCs), which bind or dissolve oxygen and act as transport vectors, and (2) kosmotropes, which increase water hydrogen bonding and thereby decrease the resistance to oxygen movement caused by the blood plasma. Dodecafluoropentane emulsion (DDFPe) was chosen to represent the AOC subset while trans sodium crocetinate (TSC) was selected to represent the kosmotrope subset. PEG-Telomer-B (PTB), the surfactant utilised to encapsulate DDFP in emulsion form, was also tested to determine whether it affected the oxygen transport ability of DDFPe. The in vitro set-up was used to simulate a semi closed-loop circulatory system, in which oxygen could be delivered from the lungs to hypoxic tissues. Results of this study showed that (1) 0.5 ml of a PFC outperformed 6.25 ml of a kosmotrope in a controlled, in vitro setting and (2) that PTB and sucrose do not contribute to the overall oxygen transportation efficacy of DDFPe. These results could be therapeutically beneficial to ongoing and future pre-clinical and clinical studies involving various oxygenation agents.